Search
7 days ago
The CEO of Seoul based Bridge Biotherapeutics discusses the importance of drug development experience - a lead program in IPF is scheduled to have a key phase 2 readout next spring
CEO Jame Lee, a founder of multiple biotech companies, describes the operational experience that he suggests is a key differentiator for...